ArticleJournal of gynecologic oncology2019

PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.

Yafang Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.